After-Hours Movers 5/28: Alfacell (ACEL) Sinks On Trial Failure; Jo-Ann Stores (JAS) Up On Results/Guidance - Street Insider

Sign Up | Log In | What is SocialPicks?

After-Hours Movers 5/28: Alfacell (ACEL) Sinks On Trial Failure; Jo-Ann Stores (JAS) Up On Results/Guidance
May 28, 2008 09:58 PM UTC

Street Insider

Return	Risk
+0.33%	MID

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
ACEL	n/a
JAS	n/a

Via StreetInsider.com News Articles:

StreetInsider.com After-Hours Movers:

Alfacell Corporation (Nasdaq: ACEL) 64.7% LOWER; announced that the preliminary statistical analysis of data from its confirmatory Phase IIIb clinical trial of its lead compound, ONCONASE, did not meet statistical significance for the primary endpoint of survival in unresectable malignant mesothelioma (UMM). However, a statistically significant improvement in survival was seen in the treatment of UMM patients who failed one prior chemotherapy regimen. Alfacell plans to submit a New Drug Application (NDA) to the FDA for the treatment of this patient population, which represents a currently unmet medical need

Jo-Ann Stores, Inc. (NYSE: JAS) 7.4% HIGHER; reports

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.